依帕司他联合葛酮通络胶囊治疗糖尿病周围神经病变的临床疗效

苏金刚，樊锁兵，权海侠，韩文占

（陕西省扶风县人民医院内分泌科，陕西 宝鸡，722200）

浏览次数：198次 下载次数：318次

摘要：

目的 观察葛酮通络胶囊联合依帕司他治疗糖尿病周围神经病变（DPN）的疗效。方法 将我院2014年3月至2016年2月收治的128例糖尿病周围神经病变患者分为治疗组和对照组，治疗组66例给予葛酮通络胶囊联合依帕司他治疗，对照组62例采用依帕司他治疗，观察两组患者的肌电图、空腹血糖、糖化血红蛋白、血液流变学情况和治疗效果。结果 治疗组总有效率为90.90%，高于对照组的66.13%（P<0.05）。治疗后，治疗组MNCV和SNCV均高于治疗前，且高于对照组（P<0.05）；治疗组FBG、HbA1L、rb、rp、PAD、IF较治疗前下降，且低于对照组（P<0.05）。结论 葛酮通络胶囊联合依帕司他治疗DPN，可提高临床治疗效果，适合临床推广。

关键词：糖尿病周围神经病变（DPN）；葛酮通络胶囊；依帕司他

中图分类号：R587.2文献标志码：A文章编号：2096-1413(2017)14-0153-02

Clinical effect of epalrestat combined with Getong Tongluo capsule in the treatment of diabetic peripheral neuropathy
SU Jin-gang, FAN Suo-bing, QUAN Hai-xia, HAN Wen-zhan
(Department of Endocrinology, Fufeng People`s Hospital, Baoji 722200, China)

ABSTRACT: Objective To observe the clinical effect of epalrestat combined with Getong Tongluo capsule in the treatment of diabetic peripheral neuropathy (DPN). Methods One hundred and twenty-eight cases of DPN patients from March 2014 to February 2016 were divided into treatment group and control group. Sixty-six cases in the treatment group were given Getong Tongluo capsule combined with epalrestat treatment, 62 cases in the control group were treated with epalrestat treatment. The EMG, fasting blood glucose, glycosylated hemoglobin, blood rheology and clinical effect between the two groups were observed. Results The total effective rate of the treatment group was 90.90%, which was higher than 66.13% of the control group (P<0.05). After treatment, the MNCV and SNCV of the treatment group were higher than those before treatment and the control group (P<0.05). The FBG, HbA1L, rb, rp, PAD and IF of the treatment group were lower than those before treatment and the control group (P<0.05). Conclusion Getong Tongluo capsule combined with epalrestat in the treatment of DPN can improve the clinical curative effect, which is suitable for clinical application.
KEYWORDS: diabetic peripheral neuropathy; Getong Tongluo capsule; epalrestat

参考文献：
[1] 艾德华,田淑艳,唐立峰.依帕司他联合肌氨肽苷治疗糖尿病周围神经病变的临床疗效观察[J].医学综述,2013,19(5):933-934.
[2] 韩隆元.硫辛酸与依帕司他联合门冬胰岛素30治疗2型糖尿病周围神经病变疗效观察[J].中国医药,2012,7(2):163-165.
[3] 张广颖,夏彩霞,杨俐,等.复方丹参滴丸联合依帕司他治疗2型糖尿病周围神经病变疗效观察[J].河北医药,2012,34(2):219-220.
[4] 宋军俊.联合应用依帕司他和甲钴胺治疗糖尿病周围神经病变的疗效观察[J].世界中医药,2016,11(3):1506-1507.
[5] 欧玉玲.甲钴胺联合前列地尔与依帕司他治疗糖尿病周围神经病变的疗效观察[J].广西医学,2013,35(12):1681-1683.
[6] 张春驰,贺昕,董艳娟,等.甲钴胺联合依帕司他治疗糖尿病周围神经病变疗效观察[J].现代仪器与医疗,2013,19(4):31-33.
[7] 古东海,何小洁,张妍.依帕司他联合银杏注射液治疗糖尿病周围神经病变疗效观察[J].广东医学,2011,32(12):1618-1619.
[8] 艾德华,田淑艳,唐立峰.依帕司他联合肌氨肽苷治疗糖尿病周围神经病变的临床疗效观察[J].医学综述,2013,19(5):933-934.